GOLDMAN SACHS GROUP INC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.7%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$623,980
-5.0%
605,806
+7.0%
0.00%
Q2 2023$656,634
+7.6%
566,064
+40.0%
0.00%
Q1 2023$610,506
-78.8%
404,309
-64.9%
0.00%
-100.0%
Q4 2022$2,882,378
-70.3%
1,152,951
-49.9%
0.00%
-50.0%
Q3 2022$9,702,000
+172.8%
2,299,053
+80.4%
0.00%
+100.0%
Q2 2022$3,556,000
-72.7%
1,274,699
-44.1%
0.00%
-66.7%
Q1 2022$13,039,000
-25.6%
2,279,598
+18.8%
0.00%0.0%
Q4 2021$17,515,000
+2.3%
1,918,410
+19.8%
0.00%
-25.0%
Q3 2021$17,125,000
+59.2%
1,601,856
+131.2%
0.00%
+100.0%
Q2 2021$10,755,000
-45.9%
692,966
-43.4%
0.00%
-60.0%
Q1 2021$19,862,000
-18.2%
1,225,285
+6.7%
0.01%
-16.7%
Q4 2020$24,296,000
+58.7%
1,147,942
+11.1%
0.01%
+50.0%
Q3 2020$15,309,000
-12.3%
1,032,984
-13.0%
0.00%
-20.0%
Q2 2020$17,460,000
+0.1%
1,186,955
-20.1%
0.01%
-16.7%
Q1 2020$17,440,000
-51.7%
1,485,527
-3.4%
0.01%
-33.3%
Q4 2019$36,134,000
+183.0%
1,537,619
+122.8%
0.01%
+125.0%
Q3 2019$12,766,000
-24.3%
690,041
-24.0%
0.00%
-20.0%
Q2 2019$16,869,000
-12.7%
907,411
+14.7%
0.01%
-16.7%
Q1 2019$19,333,000
+7.0%
791,071
+13.6%
0.01%0.0%
Q4 2018$18,064,000
+5.0%
696,406
+28.2%
0.01%
+50.0%
Q3 2018$17,196,000
-7.8%
543,320
+13.2%
0.00%
-20.0%
Q2 2018$18,649,000
+116.3%
480,027
+53.6%
0.01%
+150.0%
Q1 2018$8,623,000
+156.0%
312,432
+67.9%
0.00%
+100.0%
Q4 2017$3,368,000
-33.6%
186,072
-40.7%
0.00%0.0%
Q3 2017$5,070,000
-12.8%
313,903
-25.3%
0.00%0.0%
Q2 2017$5,817,000
+69.8%
419,980
+83.9%
0.00%0.0%
Q1 2017$3,425,000
+823.2%
228,318
+706.4%
0.00%
Q4 2016$371,000
-50.5%
28,314
-34.8%
0.00%
Q3 2016$749,000
+137.0%
43,417
+147.9%
0.00%
Q2 2016$316,000
-93.6%
17,513
-93.3%
0.00%
-100.0%
Q1 2016$4,969,000
+193.8%
261,671
+313.3%
0.00%
Q4 2015$1,691,000
-96.9%
63,317
-97.2%
0.00%
-100.0%
Q3 2015$54,877,000
+11428.8%
2,249,039
+14627.5%
0.02%
Q2 2015$476,000
-3.4%
15,271
-61.8%
0.00%
Q2 2014$493,000
+110.7%
39,986
+138.0%
0.00%
Q1 2014$234,00016,8030.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders